Construction method of humanized transgenic mouse model of chimeric human HLA-DP genome region

A technology of transgenic mice and construction methods, which can be applied to other methods of inserting foreign genetic materials, recombinant DNA technology, and the use of microinjection methods, and can solve problems such as genetic linkage disequilibrium and the lack of humanized transgenic mouse models

Pending Publication Date: 2021-03-30
SHANGHAI PUBLIC HEALTH CLINICAL CENT
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compared with the DQ and DR loci, there are fewer humanized transgenic mouse models for the DP locus, and only three DP transgenic mice (HLA-DPB1*0401, HLA-DPB1*0201, HLA-DPB1 *1701), for the study of the molecular mechanism of human chronic beryllium disease (Tarantino-Hutchison et al. 2009, Mack et al. 2014); there are many genetic linkage disequilibrium phenomena in the HLA-DP gene; February 2013 WHO IMGT / HLA database (http : / / www.ebi.ac.uk / imgt / hla / , Release3.11.0) published HLA-DPA1 and HLA-DPB1 alleles were 36 and 159; however, HLA-DPA1*0103 / DPB1* 0401 (DP401) and HLA-DPA1*0103 / DPB1*0402 (DP402) two genotypes are distributed in 20-60% of the world population, and DP401 and DP402 share similar antigenic determinants (Castelli et al. 2002, JUNBAO et al. 2005 , Sidney et al. 2010); and studies have shown that HLA-DP4 can present various polypeptides from influenza virus, HIV virus, and tumor cells to CD4 cells (Castelli et al. 2002, JUNBAO et al. 2005, Cohen et al. 2006, Sidney et al. 2010)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method of humanized transgenic mouse model of chimeric human HLA-DP genome region
  • Construction method of humanized transgenic mouse model of chimeric human HLA-DP genome region
  • Construction method of humanized transgenic mouse model of chimeric human HLA-DP genome region

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Identification and purification of embodiment 1 BAC clone

[0053] The DH10B puncture bacteria of the BAC clone CH501-138A21 containing the target gene were inoculated by streaking onto solid LB medium containing chloramphenicol (12.5ug / ml), and cultured at 37°C for 16 hours. Pick a single colony and inoculate it into 5ml of liquid LB medium containing chloramphenicol (12.5ug / ml) and shake it overnight. On the next day, BACDNA was extracted according to the conventional alkaline lysis method, and dissolved in TE for later use.

[0054] Gene sequences were amplified by conventional PCR using specific primers, and BAC clones were identified by sequencing. The sequences of the identification primers used are as follows: P1: 5'-TGTTGCCTCCTTCTTCTTCCCC-3'P2: 5'-TGGAATAGAGGATGCCAGGAG--3', to amplify a 1067bp HLA-DPA1 fragment. P3: 5'-CTCCTCTTCCCATCCTG-3'P4: 5'-TCATCCACTTTTCTCCCC-3', a 1478bp HLA-DOA fragment was amplified. P5: 5'-GAAGGAAGGAAGGAAGGAAGG-3'P6: 5'-GAAGAAAGATGGG...

Embodiment 2

[0057] Preparation and identification of embodiment 2 transgenic mice

[0058] Use the plasmid extraction kit XXX to extract the BAC clone CH501-138A21, dissolve it in TE, and confirm the integrity of the extracted BAC DNA by pulse-field gel electrophoresis. Use microinjection solution (XXX) to adjust the final concentration to 2ng / ul. Microinjection, the injected egg cells are transplanted into the fallopian tubes of pseudopregnant mice, and the mice are delivered about 20 days after pregnancy.

[0059] Identification of the first transgenic mouse (F0) by PCR method: Clipping the tail of the 15-day-old mouse, extracting the genomic DNA, using primers (P7: 5'-GAGGATTAGATGAGAGTGGCG-3'P8: 5'-ATGAATCCCCAACCCAAAGTC-3') and primers (P1: 5'-TGTTGCTCCTTCTTCTTCCCC-3'P2: 5'-TGGAATAGAGGATGCCAGGAG--3') for primary screening, PCR amplification of DPB1 and DPA1 genes, positive mice can obtain about 445bp HLA-DPB1ex2 fragment and 1067bp HLA- DPA1 fragment, for the positive mice obtained in...

Embodiment 3

[0063] Example 3 RT-PCR and quantitative PCR method to detect the expression of exogenous transgene in the main tissues of mice

[0064] According to the kit instructions, use Easypure@RNA kit (Trans, Beijing) to extract the total RNA in blood cells, spleen, and lung tissues of normal and transgenic mice, digest with DNAaseI, and reverse transcribe (Yeasen, shanghai) to generate the first strand cDNA , using real-time PCR reaction on blood cells, spleen, lung tissue cDNA, internal reference GAPDH, primers: P175'-GTACAGACGCATAGACCAACAG-3'P185'-GAACTTGTCAATGTGGCAGATG-3', amplified 300bp HLA-DPA1 cDNA fragment; P19 5' -GGAACAGCCAGAAGGACATC-3'P20 5'-CAGGAACCATCGGACTTGAAT-3', amplify 217bp of HLA-DPB1 cDNA fragment, P21 5'-GCCTCAGTTCCCTCATCAC-3'P22 5'-CCTAAGTCCTCTTCTGTTCA-3', amplify 886bp of RT-PCR-DPA1 cDNA Fragment; P23 5'-GTAATGGAGACTGGACCTTC-3'P24 5'-GACTTCAGAGCAACTTCTTG-3', amplified 386bp RT-PCR-DPB1 cDNA fragment; RT-PCR-DPA1-V2V3 cDNA fragment; PCR reaction conditions: 95...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biology, and relates to a construction method of a transgenic animal model for expressing a human HLA-DP genome region. The BAC clones an HLADP genome region (DOA-DPA1*0103-DPB1*0401) containing 124kb, BAC-DNA is introduced into fertilized eggs of mice through a prokaryotic microinjection technology after DNA sequencing, pulsed field gel electrophoresis identification and purification, and then the fertilized eggs are transplanted into fallopian tubes of false pregnant mice to obtain positive transgenic animals. Hybridizing with wild type mice isconducted to obtain filial generations, and identifying and analyzing are conducted through molecular biology, immunology and histology technologies to finally obtain five transgenic mouse lines integrating different human HLADP genome regions. The mouse model constructed by the method has high-level expression of HLA-DPA1 and HLA-DPB1 on main tissues and organs such as blood cells, spleen and lung, and can be used for T cell epitope and immune pathopoiesis and immune protection effect research of epitope-specific T cells.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a method for constructing a humanized transgenic mouse model of a chimeric human HLA-DP genome region, in particular to a human MHC (HLA-DPA1*0103-DPB1*0401) transgenic mouse model. build method. Background technique [0002] The prior art discloses that the major histocompatibility complex (MHC) is a group of genes that determine whether the transplanted tissue is compatible, is closely related to the immune response, and is closely linked. In humans, MHC is called human leukocyte antigen (HLA) gene complex. Studies have disclosed that the various genes that make up MHC are distributed in clusters on the short arm of human chromosome 6, mainly including HLA class I, HLA class II and HLA class III genes, of which HLA class II genes mainly include HLA-DP HLA-DQ, HLA-DR and other three types of gene clusters, which encode HLA class II molecules HLA-DP, HLA-DQ, HLA-DR, etc.; HLA class I...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/89A01K67/027
CPCC12N15/89A01K67/0278A01K2227/105A01K2267/0337A01K2267/0331A01K2217/05
Inventor 李峰周晓辉朱孟敏牛博文秦波音彭秀华刘玲玲陈丽香徐春华王超
Owner SHANGHAI PUBLIC HEALTH CLINICAL CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products